AEMD
Price
$0.38
Change
-$0.00 (-0.00%)
Updated
Apr 25 closing price
Capitalization
4.4M
IDXX
Price
$437.44
Change
-$3.54 (-0.80%)
Updated
Apr 25 closing price
Capitalization
44.84B
5 days until earnings call
Ad is loading...

AEMD vs IDXX

Header iconAEMD vs IDXX Comparison
Open Charts AEMD vs IDXXBanner chart's image
Aethlon Medical
Price$0.38
Change-$0.00 (-0.00%)
Volume$124.15K
Capitalization4.4M
IDEXX Laboratories
Price$437.44
Change-$3.54 (-0.80%)
Volume$939.27K
Capitalization44.84B
AEMD vs IDXX Comparison Chart
Loading...
AEMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AEMD vs. IDXX commentary
Apr 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEMD is a StrongBuy and IDXX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 27, 2025
Stock price -- (AEMD: $0.38 vs. IDXX: $437.44)
Brand notoriety: AEMD and IDXX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AEMD: 80% vs. IDXX: 106%
Market capitalization -- AEMD: $4.4M vs. IDXX: $44.84B
AEMD [@Medical Specialties] is valued at $4.4M. IDXX’s [@Medical Specialties] market capitalization is $44.84B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEMD’s FA Score shows that 1 FA rating(s) are green whileIDXX’s FA Score has 1 green FA rating(s).

  • AEMD’s FA Score: 1 green, 4 red.
  • IDXX’s FA Score: 1 green, 4 red.
According to our system of comparison, IDXX is a better buy in the long-term than AEMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEMD’s TA Score shows that 4 TA indicator(s) are bullish while IDXX’s TA Score has 6 bullish TA indicator(s).

  • AEMD’s TA Score: 4 bullish, 5 bearish.
  • IDXX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IDXX is a better buy in the short-term than AEMD.

Price Growth

AEMD (@Medical Specialties) experienced а +6.21% price change this week, while IDXX (@Medical Specialties) price change was +6.31% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.62%. For the same industry, the average monthly price growth was -3.92%, and the average quarterly price growth was -1.88%.

Reported Earning Dates

AEMD is expected to report earnings on Feb 14, 2024.

IDXX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Specialties (+5.62% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDXX($44.8B) has a higher market cap than AEMD($4.4M). IDXX YTD gains are higher at: 5.805 vs. AEMD (-55.663). IDXX has higher annual earnings (EBITDA): 1.22B vs. AEMD (-12.28M). IDXX has more cash in the bank: 454M vs. AEMD (7.97M). AEMD has less debt than IDXX: AEMD (1.01M) vs IDXX (1.07B). IDXX has higher revenues than AEMD: IDXX (3.66B) vs AEMD (574K).
AEMDIDXXAEMD / IDXX
Capitalization4.4M44.8B0%
EBITDA-12.28M1.22B-1%
Gain YTD-55.6635.805-959%
P/E RatioN/A52.87-
Revenue574K3.66B0%
Total Cash7.97M454M2%
Total Debt1.01M1.07B0%
FUNDAMENTALS RATINGS
AEMD vs IDXX: Fundamental Ratings
AEMD
IDXX
OUTLOOK RATING
1..100
918
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
9618
PRICE GROWTH RATING
1..100
6550
P/E GROWTH RATING
1..100
10067
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AEMD's Valuation (31) in the Medical Specialties industry is somewhat better than the same rating for IDXX (84). This means that AEMD’s stock grew somewhat faster than IDXX’s over the last 12 months.

IDXX's Profit vs Risk Rating (58) in the Medical Specialties industry is somewhat better than the same rating for AEMD (100). This means that IDXX’s stock grew somewhat faster than AEMD’s over the last 12 months.

IDXX's SMR Rating (18) in the Medical Specialties industry is significantly better than the same rating for AEMD (96). This means that IDXX’s stock grew significantly faster than AEMD’s over the last 12 months.

IDXX's Price Growth Rating (50) in the Medical Specialties industry is in the same range as AEMD (65). This means that IDXX’s stock grew similarly to AEMD’s over the last 12 months.

IDXX's P/E Growth Rating (67) in the Medical Specialties industry is somewhat better than the same rating for AEMD (100). This means that IDXX’s stock grew somewhat faster than AEMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AEMDIDXX
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 24 days ago
88%
Bearish Trend 11 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
64%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
AEMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLG11.730.46
+4.08%
Flagstar Financial Inc
MRAM5.480.08
+1.48%
Everspin Technologies
SVM3.72-0.07
-1.85%
Silvercorp Metals
HTHT33.75-0.78
-2.26%
H World Group Limited
NCNA0.55-0.10
-15.37%
NuCana plc

AEMD and

Correlation & Price change

A.I.dvisor tells us that AEMD and GNGBY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AEMD and GNGBY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AEMD
1D Price
Change %
AEMD100%
+1.60%
GNGBY - AEMD
26%
Poorly correlated
+0.03%
CODX - AEMD
26%
Poorly correlated
-2.78%
IDXX - AEMD
25%
Poorly correlated
-0.80%
CSTL - AEMD
25%
Poorly correlated
-1.43%
RBOT - AEMD
24%
Poorly correlated
+27.37%
More